Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL
Pharma
CSL projects a return to growth for plasma unit Behring
After impairments, downgrades and the ousting of its CEO, CSL has flashed signs of recovery, projecting growth for its plasma unit CSL Behring.
Kevin Dunleavy
Aug 18, 2026 11:35am
EU regulators offer post-mortem of Tavneos withdrawal decision
Aug 14, 2026 11:04am
Sanofi offers commitments to end EU flu shot antitrust probe
Jul 8, 2026 4:26pm
EC begins antitrust probe into Sanofi's flu shot campaign
Jun 26, 2026 11:20am
CSL cuts FY26 revenue projection by $600M, writes off $5B
May 11, 2026 11:30am
Top 20 pharma companies by 2025 revenue
Apr 20, 2026 3:00am
